StonvexLoading…
StonvexStonvexStonvexCore line items from OTEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.90B | $2.61B | $1.29B | $5.17B |
Operating Income | $762.92M | $561.70M | $269.95M | $892.69M |
Net Income | $487.36M | $314.71M | $146.62M | $435.87M |
EPS (Diluted) | $1.94 | $1.24 | $0.58 | $1.65 |
Total Assets | $13.33B | $13.57B | $13.48B | $13.77B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.25B | $1.27B | $1.09B | $1.16B |
Free Cash Flow OCF − CapEx | $685.55M | $380.67M | $101.23M | $687.40M |
Shares Outstanding | 242.23M | 251.68M | 251.96M | 254.78M |